They present differently depending on the underlying cause and the individual experiencing them
Tirzepatide is a dual GLP-1 and GIP receptor agonist that demands careful handling to maintain its therapeutic integrity
Log your own responses
Cascone T, William WN Jr, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G Jr, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG , Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B
Everyones digestive system is different
Provider Consultation: A licensed healthcare provider reviews your profile to determine if a GLP-1 medication is appropriate for you